Found: 194
Select item for more details and to access through your institution.
Ruxolitinib dose management as a key to long-term treatment success.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Insomnia as an Unmet Need in Patients With Chronic Hematological Cancer: Protocol for a Randomized Controlled Trial Evaluating a Consumer-Based Meditation App for Treatment of Sleep Disturbance.
- Published in:
- JMIR Research Protocols, 2022, v. 11, n. 7, p. 1, doi. 10.2196/39007
- By:
- Publication type:
- Article
Ruxolitinib.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 2, p. 103, doi. 10.1038/nrd3652
- By:
- Publication type:
- Article
Long-term survival in patients treated with ruxolitinib for myelofibrosis: COMFORT-I and -II pooled analyses.
- Published in:
- Journal of Hematology & Oncology, 2017, v. 10, p. 1, doi. 10.1186/s13045-017-0527-7
- By:
- Publication type:
- Article
Ironía, parrhesía, cinismo y posverdad como despligues de la intención del discurso.
- Published in:
- Tonos Digital: Revista de Estudios Filológicos, 2021, n. 41, p. 1
- By:
- Publication type:
- Article
The therapy of myelofibrosis: targeting pathogenesis.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Clinical and scientific advances in the Philadelphia-chromosome negative chronic myeloproliferative disorders.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Análisis y viabilidad de la reducción de productos químicos en los lavados de la ultrafiltración como tecnología de pretratamiento de la desalación por osmosis inversa.
- Published in:
- DYNA - Ingeniería e Industria, 2022, v. 97, n. 6, p. 658, doi. 10.6036/10454
- By:
- Publication type:
- Article
Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research.
- Published in:
- BMC Complementary & Alternative Medicine, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12906-019-2530-8
- By:
- Publication type:
- Article
Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: results from the living with MPNs survey.
- Published in:
- 2018
- By:
- Publication type:
- journal article
ATREVERSE A DECIR LA VERDAD DESDE EL BUEN CIUDADANO GRIEGO, AL RELATIVISMO DE NIETZSCHE Y EL CUIDADO DE SÍ EN FOUCAULT.
- Published in:
- Sophia, Colección de Filosofía de la Educación, 2022, n. 33, p. 199, doi. 10.17163/soph.n33.2022.07
- By:
- Publication type:
- Article
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22095-2
- By:
- Publication type:
- Article
Asian-variant intravascular lymphoma in the African race.
- Published in:
- Rare Tumors, 2012, v. 4, n. 1, p. 26, doi. 10.4081/rt.2012.e10
- By:
- Publication type:
- Article
Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.
- Published in:
- Biologics: Targets & Therapy, 2007, v. 1, n. 2, p. 129
- By:
- Publication type:
- Article
Correction: Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Childhood cancer survival in the highly vulnerable population of South Texas: A cohort study.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0278354
- By:
- Publication type:
- Article
Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development.
- Published in:
- Mediators of Inflammation, 2015, v. 2015, p. 1, doi. 10.1155/2015/284706
- By:
- Publication type:
- Article
LA IDENTIDAD PERSONAL COMO TIEMPO NARRADO Y RELATO DE FICCIÓN.
- Published in:
- Alpha: Revista de Artes, Letras y Filosofía, 2022, n. 55, p. 73, doi. 10.32735/S0718-22012022000551093
- By:
- Publication type:
- Article
Extending Jak2V617F and MplW515 Mutation Analysis to Single Hematopoietic Colonies and B and T Lymphocytes.
- Published in:
- Stem Cells, 2007, v. 25, n. 9, p. 2358, doi. 10.1634/stemcells.2007-0175
- By:
- Publication type:
- Article
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 48, doi. 10.1111/bjh.19557
- By:
- Publication type:
- Article
Quality of life independently predicts overall survival in myelofibrosis: Key insights from the COntrolled MyeloFibrosis Study with ORal Janus kinase inhibitor Treatment (COMFORT)‐I study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 6, p. 1065, doi. 10.1111/bjh.18329
- By:
- Publication type:
- Article
Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 2, p. 317, doi. 10.1111/bjh.18207
- By:
- Publication type:
- Article
A phase 2 study of simtuzumab in patients with primary, post-polycythaemia vera or post-essential thrombocythaemia myelofibrosis.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 6, p. 939, doi. 10.1111/bjh.14501
- By:
- Publication type:
- Article
The efficacy and safety of continued hydroxycarbamide therapy versus switching to ruxolitinib in patients with polycythaemia vera: a randomized, double-blind, double-dummy, symptom study (RELIEF).
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 76, doi. 10.1111/bjh.14382
- By:
- Publication type:
- Article
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 3, p. 418, doi. 10.1111/bjh.12985
- By:
- Publication type:
- Article
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 1, doi. 10.1111/bjh.12985
- By:
- Publication type:
- Article
Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 3, p. 326, doi. 10.1111/bjh.12384
- By:
- Publication type:
- Article
Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy.
- Published in:
- British Journal of Haematology, 2013, v. 162, n. 2, p. 229, doi. 10.1111/bjh.12375
- By:
- Publication type:
- Article
<sup>99m</sup>Tc-Sulfur Colloid Bone Marrow Scintigraphy in Diagnosis of Diffuse Pulmonary Extramedullary Hematopoiesis Secondary to Myelofibrosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Construcción del Derecho de las Audiencias: el Caso de las Defensorías del Televidente en Colombia.
- Published in:
- Law, State & Telecommunications Review / Revista de Direito, Estado e Telecomunicações, 2022, v. 14, n. 1, p. 139, doi. 10.26512/lstr.v14i1.37717
- By:
- Publication type:
- Article
Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 9, p. 3573, doi. 10.1007/s00277-024-05912-8
- By:
- Publication type:
- Article
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 8, p. 2837, doi. 10.1007/s00277-024-05735-7
- By:
- Publication type:
- Article
Real-world risk assessment and treatment initiation among patients with myelofibrosis at community oncology practices in the United States.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 11, p. 2555, doi. 10.1007/s00277-020-04055-w
- By:
- Publication type:
- Article
Management of myelofibrosis after ruxolitinib failure.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Relationship between symptom burden and disability leave among patients with myeloproliferative neoplasms (MPNs): findings from the Living with MPN patient survey.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Management of extreme thrombocytosis in myeloproliferative neoplasms: an international physician survey.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Current and future treatment options for polycythemia vera.
- Published in:
- Annals of Hematology, 2015, v. 94, n. 6, p. 901, doi. 10.1007/s00277-015-2357-4
- By:
- Publication type:
- Article
Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of Life.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 7, p. 521
- By:
- Publication type:
- Article
Improving Disease Burden in Myelofibrosis: Changing the Natural History of the Disease.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 7, p. 715
- By:
- Publication type:
- Article
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping.
- Published in:
- EMBO Reports, 2023, v. 24, n. 10, p. 1, doi. 10.15252/embr.202357032
- By:
- Publication type:
- Article
Body Mass Index and Total Symptom Burden in Myeloproliferative Neoplasms Discovery of a U-shaped Association.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2202, doi. 10.3390/cancers12082202
- By:
- Publication type:
- Article
Proactive Steps to Optimize the Management of Polycythemia Vera and Myelofibrosis.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, n. 9, p. 475
- By:
- Publication type:
- Article
Highlights in Myeloproliferative Neoplasms From the 60th American Society of Hematology Annual Meeting: Commentary.
- Published in:
- Clinical Advances in Hematology & Oncology, 2019, v. 17, p. 18
- By:
- Publication type:
- Article
Refining the Management of Polycythemia Vera.
- Published in:
- Clinical Advances in Hematology & Oncology, 2018, v. 16, n. 9, p. 587
- By:
- Publication type:
- Article
Associations Between Global Mental Health and Response to an App-Based Meditation Intervention in Myeloproliferative Neoplasm Patients.
- Published in:
- Integrative Cancer Therapies, 2020, v. 19, p. 1, doi. 10.1177/1534735420927780
- By:
- Publication type:
- Article
Perceptions of Myeloproliferative Neoplasm Patients Participating in an Online Yoga Intervention: A Qualitative Study.
- Published in:
- Integrative Cancer Therapies, 2018, v. 17, n. 4, p. 1150, doi. 10.1177/1534735418808595
- By:
- Publication type:
- Article
Physical Activity as a Nonpharmacological Symptom Management Approach in Myeloproliferative Neoplasms: Recommendations for Future Research.
- Published in:
- Integrative Cancer Therapies, 2017, v. 16, n. 4, p. 439, doi. 10.1177/1534735416661417
- By:
- Publication type:
- Article